A new study led by researchers from Purdue University in West Lafayette, IN, details a way of disabling a part of the virus involved in severe acute respiratory syndrome that allows it to hide from the immune system - a finding that may lead to the development of a vaccine against the disease. The research team, says their findings may also lead to the creation of a vaccine against Middle East respiratory syndrome (MERS) - a virus related to severe acute respiratory syndrome (SARS). During the 2003 SARS outbreak, a total of 8,098 people worldwide became sick with the disease.
Last month, the Centers for Disease Control and Prevention (CDC) confirmed the first MERS infection in the US, prompting nationwide concern. As yet, there are no drugs that work against MERS and SARS, but it is certainly not through lack of trying. Medical News Today recently reported on a study led by researchers…
